Jupiter Life Line Hospitals Limited (JLHL) Q2 FY27 Financial Results: PAT ₹77.92 & Revenue ₹3,284.85 Cr(2 announcements)

Jupiter Life Line Hospitals Limited announced its Q1 FY2026 unaudited financial results on July 31, 2026, reporting revenue of ₹1,913.80 crores, profit before tax of [amount context mismatch] crores, and profit for the period of [amount not verified] after tax of ₹5.67 crores. The filing also disclosed the acquisition of Sulcus Private Limited for ₹3.78 crores and the appointment of Mr. Harshad Purani as CFO effective July 31, 2026. The company is expanding into pharmaceutical manufacturing with an estimated investment of ₹35-40 crores over 1-2 years.

Jupiter Life Line Hospitals Limited announced its unaudited Q1 FY2026 results on July 31, 2026, reporting consolidated revenue of [amount context mismatch] million and net profit of [amount context mismatch] million, reflecting strong profitability. The board approved Harshad Purani’s appointment as CFO effective immediately, alongside a strategic acquisition of Sulcus Private Limited for ₹3.78 crores to expand pharmaceutical manufacturing capabilities. The financials were reviewed with limited assurance, confirming no material misstatements, while the proposed merger with Medulla Healthcare remains pending regulatory approval and is not material to current results.